HOT STOCK

SHARES of pharmaceutical company iX Biopharma sank nearly 10 per cent on Wednesday, after it proposed a private placement of about

PHARMACEUTICAL company iX Biopharma has proposed a private placement of about 44.5 million new ordinary shares at 23 Singapore cents apiece to raise a total of S$10.2 million.

STOCKS

AMID mixed sentiment across the region, the benchmark Straits Times Index (STI) ended Wednesday at 2,648.90, up 28.71 points or 1.1 per cent.

STOCKS

REGIONAL markets were broadly softer on Tuesday, following an overnight dip in US technology heavyweights that weighed on the S&P500 index.

PHARMACEUTICAL maker iX Biopharma has commenced the supply of the drugs Wafesil and Silcapvia to patients who have consulted their doctors through telemedicine in Australia, it said in a bourse...

PHARMACEUTICAL maker iX Biopharma has commenced the supply of its Wafesil and Silcap medicines through telemedicine in Australia, it said in a bourse filing on Tuesday.

IX BIOPHARMA saw its shares surge as much as 22.4 per cent when the market opened following news of the company formalising a supply agreement with Cannatrek Medical Pty Ltd to supply Xativa in...

THE following companies saw new developments that may affect trading of their shares on Monday:

IX Biopharma has entered into an agreement with independent third party Eurofins Australia New Zealand Holding for the proposed disposal of its entire stake in its wholly-owned subsidiary, ...

PHARMACEUTICAL company iX Biopharma has sunk deeper into the red with a net loss of S$3.7 million for the second quarter ending Dec 31, 2018 from a net loss of S$3.2 million a year ago. For the...